According to VBI Vaccines 's latest financial reports the company's current revenue (TTM) is $8.68 M. In 2022 the company made a revenue of $1.08 M an increase over the years 2021 revenue that were of $0.63 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $8.12 M | 650.65% |
2022 | $1.08 M | 71.47% |
2021 | $0.63 M | -40.53% |
2020 | $1.06 M | -52.23% |
2019 | $2.22 M | -33.8% |
2018 | $3.35 M | 287.86% |
2017 | $0.86 M | 57.85% |
2016 | $0.54 M | 482.98% |
2015 | $0.09 M | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A | |
2010 | N/A | |
2009 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Onconova Therapeutics ONTX | $0.22 M | -97.40% | ๐บ๐ธ USA |
Curis CRIS | $10.02 M | 15.45% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $0.75 B | 8,575.42% | ๐บ๐ธ USA |